Julie Lecuelle

2PUBLICATIONS
3CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Oct 27, 2023
FGF/FGFR genomic amplification as a predictive biomarker for immune checkpoint blockade resistance: a short report.

Nicolas Roussot, Julie Lecuelle, Lorraine Dalens

|Mar 12, 2022
MER4 endogenous retrovirus correlated with better efficacy of anti-PD1/PD-L1 therapy in non-small cell lung cancer.

Julie Lecuelle, Laure Favier, Cléa Fraisse

Pageof 1